Found: 30
Select item for more details and to access through your institution.
Correction to: Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 4, p. 1515, doi. 10.1007/s10072-020-04969-3
- By:
- Publication type:
- Article
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.694651
- By:
- Publication type:
- Article
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 12, p. 1939, doi. 10.1177/1352458520987541
- By:
- Publication type:
- Article
Obesity worsens central inflammation and disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 10, p. 1237, doi. 10.1177/1352458519853473
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of L‐glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
- Published in:
- Journal of Neurochemistry, 2021, v. 159, n. 5, p. 857, doi. 10.1111/jnc.15518
- By:
- Publication type:
- Article
Monthly corticosteroids decrease neutralizing antibodies to IFNβ1b: a randomized trial in multiple sclerosis.
- Published in:
- Journal of Neurology, 2002, v. 249, n. 1, p. 50, doi. 10.1007/PL00007847
- By:
- Publication type:
- Article
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Characterization of Regulatory T-Cell Profiles in Alzheimer's Disease and Multiple Sclerosis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45433-3
- By:
- Publication type:
- Article
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 7, p. 4495, doi. 10.1007/s00415-024-12360-x
- By:
- Publication type:
- Article
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT).
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2182, doi. 10.1007/s00415-024-12214-6
- By:
- Publication type:
- Article
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 1, p. 24, doi. 10.1007/s00415-023-12034-0
- By:
- Publication type:
- Article
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 8, p. 2922, doi. 10.1007/s00415-021-10455-3
- By:
- Publication type:
- Article
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 6, p. 2238, doi. 10.1007/s00415-021-10412-0
- By:
- Publication type:
- Article
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 3, p. 694, doi. 10.1007/s00415-019-09625-1
- By:
- Publication type:
- Article
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 5, p. 1174, doi. 10.1007/s00415-018-8831-x
- By:
- Publication type:
- Article
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.637615
- By:
- Publication type:
- Article
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 6, p. 1, doi. 10.1111/ene.16250
- By:
- Publication type:
- Article
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
- Published in:
- Multiple Sclerosis International, 2015, v. 2015, p. 1, doi. 10.1155/2015/763418
- By:
- Publication type:
- Article
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, p. 1, doi. 10.1177/1756286420970833
- By:
- Publication type:
- Article
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420970833
- By:
- Publication type:
- Article
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.
- Published in:
- Frontiers in Molecular Neuroscience, 2024, p. 1, doi. 10.3389/fnmol.2024.1430080
- By:
- Publication type:
- Article
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.
- Published in:
- Neurology & Therapy, 2022, v. 11, n. 3, p. 1193, doi. 10.1007/s40120-022-00364-6
- By:
- Publication type:
- Article
Re-emergence of T lymphocytemediated synaptopathy in progressive multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1416133
- By:
- Publication type:
- Article
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 11/12, p. 1503, doi. 10.1177/13524585241274600
- By:
- Publication type:
- Article
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 707, doi. 10.1177/13524585241232266
- By:
- Publication type:
- Article
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 856, doi. 10.1177/13524585231167515
- By:
- Publication type:
- Article